Novel Coronavirus (COVID-19)-Associated Guillain–Barre’ Syndrome: Case Report

Novel Coronavirus (COVID-19)-Associated Guillain–Barre’ Syndrome: Case Report

Mantefardo B, Gube AA, Awlachew E, Sisay G

Bahru Mantefardo,1 Addisu Alemayehu Gube,2 Ephrem Awlachew,3 Gizaw Sisay2 1Department of Internal Medicine, School of Medicine, College of Health and Medicinal Sciences, Dilla University, Dilla, Ethiopia; 2Department of Public Health, College of Health and Medicinal Sciences, Dilla University, Dilla, Ethiopia; 3Department of Medical Laboratory, College of Health and Medicinal Science, Dilla University, Dilla, EthiopiaCorrespondence: Gizaw Sisay P.O. Box: 419 Tel +251 91 158 0679Email gizsisay@gmail.comAbstract: Though the novel corona virus (COVID-19) mostly affects the respiratory system, it can also result in several neurological complications. One of these is Guillain-Barré Syndrome (GBS) and which is rare and only reported from some parts of the world during this pandemic. Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy. Patients can present with limb or cranial-nerves weakness, loss of deep tendon reflexes, sensory and dysautonomic symptoms. The main pathophysiology for the clinical presentation is demyelination and/or axonal damage to peripheral nerves or roots. Neurological manifestations are more commonly associated with severe COVID-19 infection. Here, we present a case of Guillain–Barré syndrome associated with COVID-19 in Ethiopia.Keywords: COVID-19, Guillain–Barré syndrome, neurology, Ethiopia

2021

covid-19, Ethiopia, neurology, Guillain–Barre syndrome

Biotemas

Universidade Federal de Santa Catarina

Medicine (General)